TY - JOUR
T1 - Clinicians' ability to diagnose dementia with Lewy bodies is not affected by β-amyloid load
AU - Tiraboschi, Pietro
AU - Attems, Johannes
AU - Thomas, Alan
AU - Brown, Andrew
AU - Jaros, Evelyn
AU - Lett, Debbie J.
AU - Ossola, Maria
AU - Perry, Robert H.
AU - Ramsay, Lynne
AU - Walker, Lauren
AU - McKeith, Ian G.
PY - 2014
Y1 - 2014
N2 - Objective: To investigate whether an increasing load of β-amyloid and/or neuritic plaques influences the phenotype, and thus the clinical diagnostic accuracy, of dementia with Lewy bodies (DLB). Methods: A series of 64 subjects with autopsy-proven DLB was studied. Last diagnosis before death was used to determine the clinical diagnostic accuracy of DLB in relation to Lewy body distribution and extent of Alzheimer β-amyloid and/or neuritic pathology. DLB pathologic diagnosis was made according to consensus criteria, using a-synuclein immunostaining for Lewy body identification. β-Amyloid immunostaining was used for quantifying β-amyloid deposits. The Consortium to Establish a Registry for Alzheimer's Disease criteria and Braak stage were applied for semiquantitative grading of neuritic plaque and neurofibrillary tangle pathology. Results: Overall clinical diagnostic accuracy for the entire DLB cohort was high (80%), reflecting the high prevalence of core clinical features (fluctuations [81%], parkinsonism [77%], visual hallucinations [70%]). Lower frequencies of core clinical features of DLB, resulting in lower accuracy of its clinical diagnosis, were associated with decreasing Lewy body distribution (p = 0.0001) and with increasing neuritic plaque pathology (p 5 0.035), but not with the number of β-amyloid plaque deposits. Conclusions: The likelihood of occurrence of the DLB clinical syndrome is positively related to the extent of Lewy body pathology and negatively related to the severity of Alzheimer neuritic pathology, while β-amyloid load has no effect.
AB - Objective: To investigate whether an increasing load of β-amyloid and/or neuritic plaques influences the phenotype, and thus the clinical diagnostic accuracy, of dementia with Lewy bodies (DLB). Methods: A series of 64 subjects with autopsy-proven DLB was studied. Last diagnosis before death was used to determine the clinical diagnostic accuracy of DLB in relation to Lewy body distribution and extent of Alzheimer β-amyloid and/or neuritic pathology. DLB pathologic diagnosis was made according to consensus criteria, using a-synuclein immunostaining for Lewy body identification. β-Amyloid immunostaining was used for quantifying β-amyloid deposits. The Consortium to Establish a Registry for Alzheimer's Disease criteria and Braak stage were applied for semiquantitative grading of neuritic plaque and neurofibrillary tangle pathology. Results: Overall clinical diagnostic accuracy for the entire DLB cohort was high (80%), reflecting the high prevalence of core clinical features (fluctuations [81%], parkinsonism [77%], visual hallucinations [70%]). Lower frequencies of core clinical features of DLB, resulting in lower accuracy of its clinical diagnosis, were associated with decreasing Lewy body distribution (p = 0.0001) and with increasing neuritic plaque pathology (p 5 0.035), but not with the number of β-amyloid plaque deposits. Conclusions: The likelihood of occurrence of the DLB clinical syndrome is positively related to the extent of Lewy body pathology and negatively related to the severity of Alzheimer neuritic pathology, while β-amyloid load has no effect.
UR - http://www.scopus.com/inward/record.url?scp=84925959181&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84925959181&partnerID=8YFLogxK
U2 - 10.1212/WNL.0000000000001204
DO - 10.1212/WNL.0000000000001204
M3 - Article
C2 - 25552579
AN - SCOPUS:84925959181
VL - 84
SP - 496
EP - 499
JO - Neurology
JF - Neurology
SN - 0028-3878
IS - 5
ER -